Skip to main content
SpringerLink
Log in

Design, synthesis and biological activities of N-(furan-2-ylmethyl)-1H-indole-3-carboxamide derivatives as epidemal growth factor receptor inhibitors and anticancer agents

  • Published:
Chemical Research in Chinese Universities Aims and scope

Abstract

A series of N-(furan-2-ylmethyl)-1H-indole-3-carboxamide derivatives(6a—6p) was designed and synthesized for developing novel indole scaffolds as anticancer agents targeting the epidemal growth factor receptor (EGFR), and the cytotoxic activities of the target compounds were evaluated against three EGFR high-expressed cancer cell lines[human lung adenocarcinoma cell line(A549), Henrietta Lacks strain of cancer cell line(HeLa) and human colorectal cancer cell line(SW480)], one EGFR low-expressed cell line(human liver cancer cell line, HepG2) and one human liver normal cell line(HL7702) using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay. Some target compounds exhibited potent anticancer activities against A549, HeLa, SW480 and weak activities on HepG2, which signifies that the target compounds are likely to be EGFR inhibitors as expected. And they showed weak cytotoxic effects on HL7702, which implies the target compounds are probably to be of low toxicity against normal cells. Among them, the target compound 1-ethyl-N-(furan-2-ylmethyl)-5-{2-{[2-(2-methoxyphenoxy)ethyl]amino}-2-oxoethoxy}-2-methyl-1H-indole-3-carboxamide(6p) with 2-{[2-(2-methoxyphenoxy)ethyl]-amino}-2-oxoethoxy group at the C5 position of the N-(furan-2-ylmethyl)-1H-indole-3-carboxamide scaffold exhibited the most potent anticancer activity. Also the binding interaction of the target compound 6p with EGFR was explored by molecular docking. Conclusively, the novel indole scaffold may be beneficial to investigate new anticancer agents for targeting the EGFR.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Pines G., Kostler W. J., Yarden Y., FEBS. Lett., 2010, 584(12), 2699

    Article  CAS  Google Scholar 

  2. Vogelstein B., Kinzler K. W., Nat. Med., 2004, 10(8), 789

    Article  CAS  Google Scholar 

  3. Misale S., Bozic I., Tong J. S., Peraza-Penton A., Lallo A., Baldi F., Lin K. H., Truini L., Bertotti1 A., Nicolantonio F. D., Nowak M. A., Zhang L., Wood K. C., Bardelli A., Nat. Commun., 2015, 6, 8305

    Article  CAS  Google Scholar 

  4. Domvri K., Zarogoulidis P., Darwiche K., Browning R. F., Li Q., Turner J. F., Kioumis I., Spyratos D., Porpodis K., Papaiwannou A., Tsiouda T., Freitag L., Zarogoulidis K., J. Cancer, 2013, 4(9), 736

    Article  CAS  Google Scholar 

  5. Koh P. K., Faivre-Finn C., Blackhall F. H., Ruysscher D. D., Cancer Treat Rev., 2012, 38(6), 626

    Article  Google Scholar 

  6. Nyati M. K., Morgan M. A., Feng F. Y., Lawrence T. S., Nat. Rev. Cancer, 2006, 6(11), 876

    Article  CAS  Google Scholar 

  7. Yarden Y., Sliwkowski M. X., Nat. Rev. Mol. Cell Biol., 2001, 2(2), 127

    Article  CAS  Google Scholar 

  8. Brand T. M., Iida M., Luthar N., Starr M. M., Huppert E. J., Wheeler D. L., Radiother. Oncol., 2013, 108(3), 370

    Article  CAS  Google Scholar 

  9. Fujii M., Int. J. Clin. Oncol., 2014, 19(2), 220

    Article  CAS  Google Scholar 

  10. Starok M., Preira P., Vayssade M., Haupt K., Salomé L., Rossi C., Biomacromolecules, 2015, 16(5), 1634

    Article  CAS  Google Scholar 

  11. Robert R. J., Pharmacol. Res., 2014, 87(1), 42

    Google Scholar 

  12. Boraei A. T. A., Gomaa M. S., Ashry E. S. H. E., Duerkop A., Eur. J. Med. Chem., 2017, 125(1), 360

    Article  CAS  Google Scholar 

  13. Gul W., Hamann M. T., Life Sci., 2005, 78(5), 442

    Article  CAS  Google Scholar 

  14. Ishikura M., Yamada K., Abe T., Nat. Prod. Rep., 2010, 27(11), 1630

    Article  CAS  Google Scholar 

  15. Kochanowska-Karamyan A. J., Hamann M. T., Chem. Rev., 2010, 110(8), 4489

    Article  CAS  Google Scholar 

  16. Sweidan K., Sabbah D. A., Bardaweel S., Dush K. A., Sheikha G. A., Mubarak M. S., Bioorg. Med. Chem. Lett., 2016, 26(11), 2685

    Article  CAS  Google Scholar 

  17. Finlay M. R. V., Anderton M., Ashton S., Ballard P., Bethel P. A., Box M. R., Bradbury R. H., Brown S. J., Butterworth S., Campbell A., J. Med. Chem., 2014, 57(20), 8249

    Article  CAS  Google Scholar 

  18. Showalter H., Bridges A. J., Zhou H. R., Sercel A. D., McMichael A., Fry D. W., J. Med. Chem., 1999, 42(26), 5464

    Article  CAS  Google Scholar 

  19. Hempel C., Najjar A., Totzke F., Schächtele C., Sippl W., Ritter C., Hilgeroth A., Med. Chem. Commun., 2016, 7(11), 2159

    Article  CAS  Google Scholar 

  20. Aziz Y. M. A., Said M. M., Shihawy H. A. E., Tolba M. F., Abouzid K. A. M., Chem. Pharm. Bull., 2015, 63, 1015

    Article  Google Scholar 

  21. Chauhan M., Rana A., Alex J. M., Negi A., Singh S., Kumar R., Bio-org. Chem., 2015, 58, 1

    CAS  Google Scholar 

  22. Smaill J. B., Gonzales A. J., Spicer J. A., Lee H., Reed J. E., Sexton K., Althaus I. W., Zhu T., Black S. L., Blaser A., Denny W. A., Ellis P. A., Fakhoury S., Harvey P. J., Hook K., McCarthy F. O. J., Palmer B. D., Rivault F., Schlosser K., Ellis T., Thompson A. M., Trachet E., Winters R. T., Tecle H., Bridges A., J. Med. Chem., 2016, 59(17), 8103

    Article  CAS  Google Scholar 

  23. Nie Y., Huang D. H., Wang F. S., Dan Y. M., Zhao J. S., Song X. J., Chinese J. Struct. Chem., 2014, 33(12), 1789

    CAS  Google Scholar 

  24. Kim Y. J., Pyo J. S., Jung Y. S., Kwak J. H., Bioorg. Med. Chem. Lett., 2017, 27(3), 607

    Article  CAS  Google Scholar 

  25. Salem M. A., Pharma Chemica, 2016, 8(4), 363

    CAS  Google Scholar 

  26. Zhou X. F., Guo J. L., Ji Y. M., Pan G. F., Liu T., Zhu H., Zhao J. P., Mol. Cancer Res., 2016, 14(5), 448

    Article  CAS  Google Scholar 

  27. Chen L. J., She X. D., Wang T., Nanoscale, 2015, 7(33), 14080

    Article  CAS  Google Scholar 

  28. Lin W. J., Kao L. T., Expert Opin. Drug Del., 2014, 11(10), 1537

    Article  CAS  Google Scholar 

  29. Stamos J., Sliwkowski M. X., Eigenbrot C., J. Biol. Chem., 2002, 277(48), 46265

    Article  CAS  Google Scholar 

  30. Velezheva V. S., Kornienko A. G., Topilin S. V., Turashev A. D., Peregudov A. S., Brennan P. J., J. Heterocyclic Chem., 2006, 43(4), 873

    Article  CAS  Google Scholar 

  31. Patrick J. B., Saunders E. K., Tetrahedron Lett., 1979, 20(42), 4009

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Key Laboratory of Structure-based Drug Design & Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang, 110016, P. R. China

    Lan Zhang, Xinshan Deng, Jiaofeng Wu, Guangpeng Meng, Congchong Liu, Guzhou Chen & Chun Hu

  2. Department of Pharmacy, General Hospital of Shenyang Military Area Command, Shenyang, 110016, P. R. China

    Qingchun Zhao

Authors
  1. Lan Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xinshan Deng
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jiaofeng Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Guangpeng Meng
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Congchong Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Guzhou Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Qingchun Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Chun Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chun Hu.

Additional information

Supported by the National Natural Science Foundation of China(No.21342006) and the Program for the Innovative Research Team of the Ministry of Education of China(No.IRT_14R36).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, L., Deng, X., Wu, J. et al. Design, synthesis and biological activities of N-(furan-2-ylmethyl)-1H-indole-3-carboxamide derivatives as epidemal growth factor receptor inhibitors and anticancer agents. Chem. Res. Chin. Univ. 33, 365–372 (2017). https://doi.org/10.1007/s40242-017-7041-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40242-017-7041-x

Keywords

Search

Navigation